Medicine & Life Sciences
Acute Kidney Injury
19%
Amines
23%
Antiviral Agents
14%
Atypical Hemolytic Uremic Syndrome
42%
B-Cell Chronic Lymphocytic Leukemia
18%
Biopsy
35%
Blood Vessels
32%
Capillaries
12%
Carbon Nanotubes
92%
Chilblains
28%
Complement Activation
53%
Complement C5
26%
Complement C5b
14%
Complement C9
13%
Complement Membrane Attack Complex
49%
Complement System Proteins
21%
Coronavirus
100%
Disease Susceptibility
18%
eculizumab
34%
Endothelial Cells
19%
Endothelium
11%
Hypereosinophilic Syndrome
24%
Infections
15%
Interferon Type I
32%
Liver
11%
Lysine
16%
Mannose-Binding Lectin Complement Pathway
11%
mepolizumab
28%
Microbiota
16%
Microvessels
27%
Nanotubes
38%
Neutrophils
13%
PCI 32765
25%
Pharmaceutical Preparations
13%
Pharmacokinetics
12%
Placenta
31%
Purpura
21%
Respiratory Insufficiency
15%
SARS Virus
56%
Severe Acute Respiratory Syndrome
28%
Skin
50%
Steroids
12%
Subcutaneous Fat
15%
Term Birth
15%
Thrombosis
39%
Thrombotic Microangiopathies
25%
Vaccines
12%
Viral Proteins
48%
Viral RNA
51%
Wounds and Injuries
13%
Chemical Compounds
1,4,7,10-tetraazacyclododecane
5%
Antigen
17%
Azomethine Ylide
5%
C60 Fullerene
6%
Carbon Atom
8%
Carbon Nanotube
64%
Clearance
11%
Cytopathic
26%
DNA Sequencing
7%
Dose
8%
Drug
11%
Effector
6%
Fibrin
20%
Fullerene
5%
Glycoprotein
15%
Intraperitoneal
7%
Lectin
17%
Lysine
8%
Mannose
18%
Nanotube
39%
Oligonucleotide
5%
Pharmacokinetics
12%
Polydispersity
5%
Procoagulant
25%
Radioisotope
7%
Separation Method
6%
Serine
16%
Single Walled Nanotube
56%
Small Interfering RNA
5%
Solubility
6%
Thermal Diffusion
5%
Engineering & Materials Science
Alpha particles
8%
Amines
28%
Amorphous carbon
8%
Antibodies
21%
Cells
5%
Cycloaddition
13%
Dimethylformamide
9%
Drug delivery
5%
Fullerenes
17%
Impurities
16%
Macromolecules
5%
Microorganisms
20%
Molecules
8%
Mucous Membrane
6%
Nanotubes
36%
Oligonucleotides
8%
Pharmacokinetics
24%
Physicochemical properties
7%
Polydispersity
8%
Radioisotopes
6%
RNA
9%
Self assembly
22%
Single-walled carbon nanotubes (SWCN)
54%
Solubility
9%
Toxicity
8%
Tumors
17%